150 related articles for article (PubMed ID: 2269800)
1. Effects of morphine on the dyspnea of terminal cancer patients.
Bruera E; Macmillan K; Pither J; MacDonald RN
J Pain Symptom Manage; 1990 Dec; 5(6):341-4. PubMed ID: 2269800
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous morphine for dyspnea in cancer patients.
Bruera E; MacEachern T; Ripamonti C; Hanson J
Ann Intern Med; 1993 Nov; 119(9):906-7. PubMed ID: 8215003
[No Abstract] [Full Text] [Related]
3. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
Gamborg H; Riis J; Christrup L; Krantz T
J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
[TBL] [Abstract][Full Text] [Related]
4. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.
Mazzocato C; Buclin T; Rapin CH
Ann Oncol; 1999 Dec; 10(12):1511-4. PubMed ID: 10643545
[TBL] [Abstract][Full Text] [Related]
5. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
[TBL] [Abstract][Full Text] [Related]
6. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
7. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
[TBL] [Abstract][Full Text] [Related]
8. Morphine in the management of dyspnoea in ALS. A pilot study.
Clemens KE; Klaschik E
Eur J Neurol; 2008 May; 15(5):445-50. PubMed ID: 18355309
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the analgesic and respiratory effects of epidural nalbuphine or morphine in postthoracotomy patients.
Etches RC; Sandler AN; Lawson SL
Anesthesiology; 1991 Jul; 75(1):9-14. PubMed ID: 2064065
[TBL] [Abstract][Full Text] [Related]
10. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias.
Matsuda Y; Maeda I; Tachibana K; Nakao K; Sasaki Y; Sugimoto C; Arai T; Tokoro A; Akira M; Inoue Y
J Palliat Med; 2017 Aug; 20(8):879-883. PubMed ID: 28437202
[TBL] [Abstract][Full Text] [Related]
12. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
Hu WY; Chiu TY; Cheng SY; Chen CY
J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
[TBL] [Abstract][Full Text] [Related]
13. Effect of nebulized morphine in cancer patients with dyspnea: a pilot study.
Tanaka K; Shima Y; Kakinuma R; Kubota K; Ohe Y; Hojo F; Matsumoto T; Ohmatsu H; Goto K; Nagai K; Nishiwaki Y
Jpn J Clin Oncol; 1999 Dec; 29(12):600-3. PubMed ID: 10721941
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
15. Continuous intravenous infusion of morphine for severe dyspnea.
Cohen MH; Anderson AJ; Krasnow SH; Spagnolo SV; Citron ML; Payne M; Fossieck BE
South Med J; 1991 Feb; 84(2):229-34. PubMed ID: 1899295
[TBL] [Abstract][Full Text] [Related]
16. Preoperative lumbar epidural morphine improves postoperative analgesia and ventilatory function after transsternal thymectomy in patients with myasthenia gravis.
Kirsch JR; Diringer MN; Borel CO; Hanley DF; Merritt WT; Bulkley GB
Crit Care Med; 1991 Dec; 19(12):1474-9. PubMed ID: 1959365
[TBL] [Abstract][Full Text] [Related]
17. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
Maeda T; Hayakawa T
J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
[TBL] [Abstract][Full Text] [Related]
18. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.
Kohara H; Ueoka H; Aoe K; Maeda T; Takeyama H; Saito R; Shima Y; Uchitomi Y
J Pain Symptom Manage; 2003 Oct; 26(4):962-7. PubMed ID: 14575057
[TBL] [Abstract][Full Text] [Related]
19. Dose-response pharmacology of intrathecal morphine in human volunteers.
Bailey PL; Rhondeau S; Schafer PG; Lu JK; Timmins BS; Foster W; Pace NL; Stanley TH
Anesthesiology; 1993 Jul; 79(1):49-59; discussion 25A. PubMed ID: 8342828
[TBL] [Abstract][Full Text] [Related]
20. Nebulized morphine for terminal dyspnea.
Westphal CG; Campbell ML
Am J Nurs; 2002 May; Suppl():11-5. PubMed ID: 12006868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
